M. Kulyk & Associates
XYL icon

M. Kulyk & Associates’s Xylem XYL Stock Holding History

M. Kulyk & Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.01M Buy
59,333
+605
+1% +$69.2K 1% 34
2026
Q2 		$6.94M Buy
58,728
+12,661
+27% +$1.46M 1.13% 33
2026
Q1 		$5.5M Buy
46,067
+3,216
+8% +$422K 1.03% 34
2025
Q4 		$5.84M Buy
42,851
+2,374
+6% +$341K 1.12% 35
2025
Q3 		$5.97M Sell
40,477
-1,549
-4% -$215K 1.21% 31
2025
Q2 		$5.44M Buy
42,026
+1,205
+3% +$146K 1.18% 30
2025
Q1 		$4.88M Buy
40,821
+596
+1% +$73.9K 1.12% 33
2024
Q4 		$4.67M Sell
40,225
-1,888
-4% -$239K 1.01% 35
2024
Q3 		$5.69M Buy
42,113
+216
+0.5% +$28.9K 1.14% 31
2024
Q2 		$5.68M Sell
41,897
-1,144
-3% -$156K 1.32% 27
2024
Q1 		$5.56M Sell
43,041
-1,437
-3% -$174K 1.29% 31
2023
Q4 		$5.09M Buy
44,478
+3,312
+8% +$331K 1.18% 35
2023
Q3 		$3.75M Sell
41,166
-232
-0.6% -$23.9K 1.04% 35
2023
Q2 		$4.66M Sell
41,398
-1,063
-3% -$112K 1.3% 30
2023
Q1 		$4.45M Buy
42,461
+1,014
+2% +$106K 1.35% 31
2022
Q4 		$4.58M Buy
41,447
+138
+0.3% +$14.5K 1.53% 25
2022
Q3 		$3.61M Sell
41,309
-15,592
-27% -$1.42M 1.25% 32
2022
Q2 		$4.45M Buy
56,901
+5,251
+10% +$434K 1.38% 28
2022
Q1 		$4.4M Buy
51,650
+9,093
+21% +$871K 1.2% 34
2021
Q4 		$5.1M Buy
42,557
+2,934
+7% +$364K 1.32% 34
2021
Q3 		$4.9M Buy
39,623
+1,053
+3% +$136K 1.57% 24
2021
Q2 		$4.63M Sell
38,570
-1,092
-3% -$125K 1.67% 26
2021
Q1 		$4.17M Buy
39,662
+2,445
+7% +$248K 1.56% 25
2020
Q4 		$3.79M Buy
+37,217
New +$3.5M 2.1% 9

Other funds holding XYL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

M. Kulyk & Associates's XYL Position: Q3 2026 in Review

M. Kulyk & Associates increased its Xylem (XYL) stake by 1% in Q3 2026, buying an estimated $69.2K and bringing the position to 59,333 shares worth $6.01M. The position accounts for 1% of the portfolio, ranked #34.

M. Kulyk & Associates first reported a position in XYL in Q4 2020 and has held it in 24 quarters since. The position peaked at $6.94M in Q2 2026. 906 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • M. Kulyk & Associates held 59,333 shares of Xylem worth $6.01M as of Q3 2026.
  • M. Kulyk & Associates bought 605 Xylem shares in Q3 2026, an estimated $69.2K.
  • Xylem made up 1% of M. Kulyk & Associates's portfolio in Q3 2026, its #34 holding.
  • M. Kulyk & Associates first reported a position in Xylem in Q4 2020 and has held it in 24 quarters since.
  • M. Kulyk & Associates's Xylem position peaked at $6.94M in Q2 2026.
  • 906 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on M. Kulyk & Associates's 13F filing for Q3 2026, filed 10 Nov 2026.